One Test’s Odyssey: Cancer Of Unknown Origin
Executive Summary
In recent years Pathwork Diagnostics Inc. and Rosetta Genomics Ltd. have developed tests that use the molecular makeup of the cancer cells to provide insight on the cancer’s origin.
You may also be interested in...
Kissei Discussing Rovatirelin Path After Mixed Phase III Results
Japanese firm in discussions with regulator as high-need novel therapy for spinocerebellar degeneration misses endpoint but shows promise in pooled analysis.
QUOTED. 24 January 2020. Megan McSeveney.
The FDA has readied plans for hastened emergency-use approvals of coronavirus test kits after an infected US citizen returned to Washington State from Wuhan province in China. See what the FDA’s Megan McSeveney said about it here.
A Tale Of Two DMD Drugs: Theme And Variation In Controversial US FDA Reviews
Despite obvious similarities in the contentious reviews of Sarepta’s Vyondys 53 and its predecessor Exondys 51, drug developers should focus on the differences between the two reviews.
Need a specific report? 1000+ reports available
Buy Reports